Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Procept BioRobotics Corp (NASDAQ: PRCT) closed the day trading at $48.12 down -2.98% from the previous closing price of $49.6. In other words, the price has decreased by -$2.98 from its previous closing price. On the day, 1.17 million shares were traded. PRCT stock price reached its highest trading level at $49.895 during the session, while it also had its lowest trading level at $48.1.
Ratios:
For a better understanding of PRCT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.74 and its Current Ratio is at 8.94. In the meantime, Its Debt-to-Equity ratio is 0.21 whereas as Long-Term Debt/Eq ratio is at 0.20.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stephens on July 09, 2025, initiated with a Overweight rating and assigned the stock a target price of $70.
On December 02, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $105.Morgan Stanley initiated its Overweight rating on December 02, 2024, with a $105 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 10 ’25 when Desai Antal Rohit sold 25,000 shares for $63.91 per share. The transaction valued at 1,597,711 led to the insider holds 64,363 shares of the business.
Desai Antal Rohit sold 25,000 shares of PRCT for $1,584,525 on Jun 11 ’25. The Director now owns 39,363 shares after completing the transaction at $63.38 per share. On Jun 12 ’25, another insider, Desai Antal Rohit, who serves as the Director of the company, sold 25,000 shares for $61.49 each. As a result, the insider received 1,537,256 and left with 14,363 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PRCT now has a Market Capitalization of 2662416896 and an Enterprise Value of 2428021504. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.69 while its Price-to-Book (P/B) ratio in mrq is 6.84. Its current Enterprise Value per Revenue stands at 9.746 whereas that against EBITDA is -26.717.
Stock Price History:
The Beta on a monthly basis for PRCT is 1.04, which has changed by -0.19893456 over the last 52 weeks, in comparison to a change of 0.21149921 over the same period for the S&P500. Over the past 52 weeks, PRCT has reached a high of $103.81, while it has fallen to a 52-week low of $47.04. The 50-Day Moving Average of the stock is -16.84%, while the 200-Day Moving Average is calculated to be -29.56%.
Shares Statistics:
Over the past 3-months, PRCT traded about 925.00K shares per day on average, while over the past 10 days, PRCT traded about 1476630 shares per day. A total of 55.28M shares are outstanding, with a floating share count of 52.60M. Insiders hold about 4.93% of the company’s shares, while institutions hold 92.02% stake in the company. Shares short for PRCT as of 1752537600 were 6823424 with a Short Ratio of 7.38, compared to 1749772800 on 6716837. Therefore, it implies a Short% of Shares Outstanding of 6823424 and a Short% of Float of 14.63.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
